刘许歌,中共党员,博士。2017年毕业于中山大学威廉希尔,取得药物化学博士学位。2017-2020年在中山大学任特聘研究员,主要的研究领域是药物及天然产物结构修饰新策略及糖肽类药物研发。2021年2月加入威廉希尔,被聘为河南大学黄河学者特聘教授。主持国家自然科学基金青年基金1项,广东省自然科学基金面上项目1项。在Nat Commun, Angew. Chem. Int. Ed, ACS Catal等期刊发表SCI论文20余篇。 邮箱:liuxg7@yeah.net
研究方向
药物化学,糖化学
代表性研究成果:
1.Zhan Li ‡, Ke-Feng Wang ‡, Xin Zhao ‡, Huihui Ti, Xu-Ge Liu *, Honggen Wang *.; “Manganese-Mediated Reductive Functionalization of Active Aliphatic Acids and Primary Amines. Nature Communications, 2020, 11: 5036.
2.Xu-Ge Liu, Chu-Jun Zhou, E Lin, Xiang-Lei Han, Shang-Shi Zhang, Qingjiang Li and Honggen Wang*. Decarboxylative Negishi Coupling of Redox-Active Aliphatic Esters with Cobalt Catalysis. Angew. Chem. Int. Ed. 2018, 57, 13096-13100.
3.Xu-Ge Liu ‡, Hui Gao ‡, Shang-Shi Zhang, Qingjiang Li, and Honggen Wang*. N-O Bond as External Oxidant in Group 9 Metal Cp*M(III)-Catalyzed Oxidative C−H Coupling Reactions. ACS Catal. 2017, 7, 5078−5086.
4.Xu-Ge Liu, Qingjiang Li, Honggen Wang*. (Pentamethylcyclopentadienyl)cobalt(III)-Catalyzed Direct Trifluoromethyl-thiolation of Arenes via C−H Activation. Adv. Synth. Catal. 2017. 359, 1942-1946.
5.Xu-Ge Liu, Shang-Shi Zhang, Chun-Yong Jiang, Jia-Qiang Wu, Qingjiang Li, Honggen Wang*. Cp*Co(III)-Catalyzed Annulations of 2Alkenylphenols with CO: Mild Access to Coumarin Derivatives. Org. Lett. 2015, 17, 5404−5407